Organogenesis Holdings Inc. (ORGO) News

Organogenesis Holdings Inc. (ORGO): $2.63

-0.09 (-3.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORGO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 379

in industry

Filter ORGO News Items

ORGO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ORGO News Highlights

  • ORGO's 30 day story count now stands at 3.
  • Over the past 1 day, the trend for ORGO's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • NOTE and NOV are the most mentioned tickers in articles about ORGO.

Latest ORGO News From Around the Web

Below are the latest news stories about ORGANOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate ORGO as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Thursday!

William White on InvestorPlace | November 10, 2022

Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript

Good afternoon, ladies and gentlemen, and welcome to the third quarter 2022 earnings conference call for Organogenesis Holdings Inc. [Operator instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated Including the risks and uncertainties described in the company's filings with the Securities and Exchange Commission, including Item 1A risk factors of the company's most recent annual report and its subsequent...

Yahoo | November 10, 2022

Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results

CANTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Financial Results Summary: Net revenue of $116.9 million for the third quarter of 2022, an increase of 3% compared

Yahoo | November 9, 2022

Organogenesis Holdings (NASDAQ:ORGO) shareholders have endured a 72% loss from investing in the stock a year ago

As every investor would know, you don't hit a homerun every time you swing. But it would be foolish to simply accept...

Yahoo | November 9, 2022

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022

CANTON, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that third quarter of fiscal year 2022 financial results will be reported after the market closes on Wednesday, November 9th. Management will host a conference call at 5:00 p.m. Eastern Time on Nove

Yahoo | September 26, 2022

Will Weakness in Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Prove Temporary Given Strong Fundamentals?

With its stock down 36% over the past three months, it is easy to disregard Organogenesis Holdings (NASDAQ:ORGO...

Yahoo | September 26, 2022

Top Pharmaceutical Stocks for Q4 2022

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2022.

Yahoo | September 16, 2022

10 Best 52-Week Low Small-Cap Stocks to Buy Now

In this article, we discuss the 10 best 52-week low small-cap stocks to buy now. If you want to skip our discussion on the overall economic environment in the US, go to 5 Best 52-Week Low Small-Cap Stocks to Buy Now. The US stock markets have come under pressure as inflation rose faster than expected […]

Yahoo | September 16, 2022

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

CANTON, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from Septem

Yahoo | September 7, 2022

FDA Clears Organogenesis' Next Generation PuraPly Surgical Solution

Organogenesis Holdings Inc (NASDAQ: ORGO) has received the FDA 510k Clearance for PuraPly MZ, a brand extension to the PuraPly product portfolio. Of the U.S.'s 40 to 50 million surgeries each year, up to 28% of surgical sites must be left open to heal. Related: Organogenesis' Q2 Operating Income Fell 50%, Lowers Annual Guidance. Organogenesis developed PuraPly MZ, a powder designed to support wound healing in deep, tunneling, and complex wounds to support clinicians and patients with these compl

Yahoo | August 15, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6286 seconds.